| Schedule of Basic and Diluted Earnings Per Share |
Shares used in the computation of the Company’s basic and diluted earnings per share are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (in thousands, except per share data) |
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
| |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
| Numerator |
|
|
|
|
|
|
|
|
| Net increase (decrease) in net assets resulting from operations |
|
$ |
41,852 |
|
|
$ |
94,775 |
|
|
$ |
132,816 |
|
|
$ |
189,339 |
|
| Less: Total distributions declared |
|
(77,894) |
|
|
(67,379) |
|
|
(153,925) |
|
|
(132,153) |
|
| Total Earnings (loss), net of total distributions |
|
(36,042) |
|
|
27,396 |
|
|
(21,109) |
|
|
57,186 |
|
|
|
|
|
|
|
|
|
|
| Earnings (loss), net of distributions attributable to common shares |
|
(36,042) |
|
|
27,108 |
|
|
(21,110) |
|
|
56,552 |
|
| Add: Distributions declared attributable to common shares |
|
77,157 |
|
|
66,672 |
|
|
152,387 |
|
|
130,696 |
|
| Numerator for basic and diluted change in net assets per common share |
|
$ |
41,115 |
|
|
$ |
93,780 |
|
|
$ |
131,277 |
|
|
$ |
187,248 |
|
|
|
|
|
|
|
|
|
|
| Denominator |
|
|
|
|
|
|
|
|
| Basic weighted average common shares outstanding |
|
160,748 |
|
141,390 |
|
159,096 |
|
138,338 |
| Common shares issuable |
|
561 |
|
694 |
|
518 |
|
1,249 |
| Weighted average common shares outstanding assuming dilution |
|
161,309 |
|
142,084 |
|
159,614 |
|
139,587 |
|
|
|
|
|
|
|
|
|
| Change in net assets per common share: |
|
|
|
|
|
|
|
|
| Basic |
|
$ |
0.26 |
|
|
$ |
0.66 |
|
|
$ |
0.83 |
|
|
$ |
1.35 |
|
| Diluted |
|
$ |
0.25 |
|
|
$ |
0.66 |
|
|
$ |
0.82 |
|
|
$ |
1.34 |
|
|
| Schedule of Number of Anti-diluted Shares as Calculated Based on Weighted Average Closing Price of Common Stock |
The calculation of change in net assets resulting from operations per common share assuming dilution, excludes all anti-dilutive shares. For the three and six months ended June 30, 2024, and 2023, the number of anti-dilutive shares, as calculated based on the weighted average closing price of the Company’s common stock for the periods, are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
| Anti-dilutive Securities |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
| Unvested common stock options |
|
798 |
|
3,146 |
|
1,401 |
|
2,499 |
| Restricted stock units |
|
— |
|
9,555 |
|
— |
|
8,714 |
| Unvested restricted stock awards |
|
147 |
|
65,346 |
|
521 |
|
59,854 |
|
|
|
|
|
|
|
|
|
|